Poster Sessions C786 peak wavelength of gold, and processed with HKL2000. Phasing, model building and refinement were conducted using PHENIX, REFMAC5, COOT and other programs of CCP4. Electron densities for the catalytic domain of the enzyme were clearly obtained, but those for the linker and PHB-binding domains were not, in spite that there is remaining space for these domains to be packed in the crystal lattice.
MS93.P50
Calcium is a ubiquitous, versatile intracellular signal regulating numerous cellular processes [1] . The versatility of Ca 2+ signalling emerges from the use of an extensive repertoire of signalling components known as a Ca 2+ signalling toolkit that can be assembled in combinations to create signals with different spatial and temporal profiles. Mobilisation of intracellular Ca 2+ stores into the cytoplasm is mediated through three structurally divergent messengers, one of them being cyclic ADP-ribose (cADPR) [2] . cADPR acts on the ryanodine receptor to elicit Ca 2+ release. it is ubiquitous across species and is an endogenous modulator of Ca 2+ -induced Ca 2+ release thereby regulating a wide range of physiological processes [3] . cADPR is a cyclic nucleotide converted from NAD + by multifunctional enzymes of the ADP-ribosyl cyclase family [4] . Aplysia ADP-ribosyl cyclase (Aplysia cyclase) was the first enzyme identified to catalyse the cyclisation of NAD + to cADPR, with the release of nicotinamide . Aplysia cyclase is a 30kDa protein initially isolated from Aplysia ovotestis [5] . It is also found to be present in the neurons of the Aplysia buccal ganglion, where production of cADPR can enhance the evoked synaptic transmission [6] . Recently, it has been shown that Aplysia cyclase translocates from the cytosol into the nucleus upon depolarisation of Aplysia neurons, providing a mechanism for selective and specific activation of the nuclear Ca 2+ store in neurons offering versatility for the neurons to respond to a wide range of stimuli [7] .
Cyclisation of NAD + into cADPR involves a two step reaction, the elimination of the nicotinamide ring and the cyclisation of the intermediate resulting in the covalent attachment of the adenine ring to the anomeric carbon of the terminal ribose. Cyclisation of NAD + results in the linkage of the adenine and terminal ribose moieties established via the N1-position of the adenine ring, while cyclisation of NAD + analogues resulted in the covalent attachment to the terminal ribose via the N7 position of the purine ring of these analogues [8] .
In this study, we have determined the structures of wildtype Aplysia cyclase complexed with its substrates, NAD + and NGD + , and its products cADPR and cGDPR. In addition, we were also able to capture the reaction intermediates of the cyclisation reaction either by controlling the soaking time of the substrate or with the use of substrate analogues. Taken together, we are able to obtain snapshots of the cyclisation process of the dinucleotide resulting in either N1 or N7 linkage of the purine ring to the terminal ribose.
[ Phosphoribosyltransferases (PRTases) are a group of enzymes that catalyze the formation of nucleotide 5´-monophosphates as essential precursors in the synthesis DNA or RNA. PRTases all use a common substrate, 5-phosphoribosyl-α-1-pyrophosphate (PRPP), and in the presence of Mg 2+ they transfer nucleobases to C1 of the ribose 5´-phosphate moiety of PRPP to form nucleotide 5´-monophosphates under the release of pyrophosphate (P 2 O 7 4-). PRTases are involved in both the de novo biosynthesis of nucleotides, e.g. orotate PRTase (OPRTase) and in the salvage pathways, e.g. uracil PRTase (UPRTase), adenine PRTase (APRTase) and hypoxantine-guanine-xanthine PRTases (HGXPRTases; often with mixed specificity). PRTases share a common domain fold (type 1) which defines the specificity for PRPP and a variable domain for recognition of the various nucleobases.
Adenine PRTase structures are known for eukaryotes and bacteria, and details of their active sites have been mapped out. APRTase from the thermophile archaean Sulfolobus solfataricus is an enzyme with unexpected properties: The substrate binding order is reversed with adenine binding first followed by PRPP. It has a double pH optimum and is potently inhibited by AMP and ADP. Phosphate PO 4 3-seems to facilitate adenine binding.
Sequentially, SsAPRTase does not resemble other APRTases but merely HGXPRTases from eukaryotes, bacteria and archaea. The closest sequence homologues in PDB (1nul [1] & 1vdm [2]) used for molecular replacement share about 31 % sequence identity for a 143/210 residue stretch of the sequence. The remaining sequence does not resemble any known structure. SsAPRTase is to our knowledge the fi rst archaean APRTase to be structurally characterized.
We will present dimeric P6 1 structures of "apo" SsAPRTase (with PO 4 3-) together with the complexes SsAPRTase:AMP (product) and SsAPRTase:ADP (inhibitor) based on ESRF (Grenoble) synchrotron data to about 2.4 Å resolution. The current work concentrates on obtaining substrate complexes of SsAPRTase. Sciences, Inst. of Pharmaceutical Science, 150 Stamford Street, London SE1 9NH, (England) . E-mail: Rene.Jorgensen@ Carlsberglab.com Glycosyltransferases (GTs) are carbohydrate-active enzymes with essential roles in numerous fundamental biological processes such as cellular adhesion, cell signaling, carcinogenesis and cell wall biosynthesis in human pathogens. These enzymes therefore underpin human health and disease and thus inhibitors of GTs are highly sought after as small molecular tools for chemical biology and as lead compounds for drug discovery. Previously, reported ground-state GT donor or acceptor analogues often possess only limited inhibitory potency and the design is complicated by the complex reaction mechanism.
Recently, new and potent GT inhibitors were developed by structural modifi cation of the UDP-galactose donor at position 5 of the uracil base (fi gure 1) [1] . Initially, we solved the crystal structure of a representative GT with the most potent UDP-sugar derivative bound. The complex structure reveals that the derivative binds in the active site in a similar manner as the natural donor, but almost completely abolishes sugar transfer by locking the target enzyme in a catalytically inactive conformation [2] . This unique mode of inhibition for GTs seems to be generally applicable to other enzymes in this family. Interestingly, new structures of other similar UDP-sugar derived inhibitors bound to the active site including binding of acceptor reveal striking adaptive dynamics of the enzyme and provide an explanation for its ability to remain slightly active. In addition, the new structures provide an explanation for the dependence of inhibitory potency on the subsituent structure. Finally, by modifying a UDP-GalNAc we have for the fi rst time obtained a structure with an intact UDP-GalNAc in the binding site of human blood group GTs. This structure reveals important aspects of the specifi city of the enzymes responsible for creating blood type A and B. These results demonstrate the dynamics of the GTs and provide a template for the development of a new class of allosteric GT inhibitors.
